Soper JT - Search Results

1

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Kohler MF, et al. Among authors: soper jt. Cancer Res. 1992 Mar 15;52(6):1622-7. Cancer Res. 1992. PMID: 1540970

2

Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer.

Olt G, Soper J, Ramakrishnan S, Xu F, Berchuck A, Clarke-Pearson D, Dodge R, Bast RC Jr. Olt G, et al. Am J Obstet Gynecol. 1996 Apr;174(4):1316-9. doi: 10.1016/s0002-9378(96)70678-6. Am J Obstet Gynecol. 1996. PMID: 8623863

3

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease.

Berchuck A, Rodriguez G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Among authors: soper jt. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):15-21. doi: 10.1016/0002-9378(91)90615-x. Am J Obstet Gynecol. 1991. PMID: 1670908

4

Isolated incisional metastases after intraperitoneal radioactive chromic phosphate therapy for ovarian carcinoma.

Kohler MF, Soper JT, Tucker JA Jr, Clarke-Pearson DL. Kohler MF, et al. Among authors: soper jt. Cancer. 1991 Sep 15;68(6):1380-3. doi: 10.1002/1097-0142(19910915)68:6<1380::aid-cncr2820680633>3.0.co;2-u. Cancer. 1991. PMID: 1831399

5

Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.

Soper JT, Berchuck A, Clarke-Pearson DL. Soper JT, et al. Cancer. 1991 Aug 15;68(4):725-9. doi: 10.1002/1097-0142(19910815)68:4<725::aid-cncr2820680410>3.0.co;2-1. Cancer. 1991. PMID: 1855171

6

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, et al. Berchuck A, et al. Among authors: soper jt. Cancer Res. 1990 Jul 1;50(13):4087-91. Cancer Res. 1990. PMID: 1972347

7

Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma.

Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr. Soper JT, et al. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1204-9. doi: 10.1016/0002-9378(90)90692-z. Am J Obstet Gynecol. 1990. PMID: 2220931

8

Epidermal growth factor receptor expression in normal and malignant endometrium.

Berchuck A, Soisson AP, Olt GJ, Soper JT, Clarke-Pearson DL, Bast RC Jr, McCarty KS Jr. Berchuck A, et al. Among authors: soper jt. Am J Obstet Gynecol. 1989 Nov;161(5):1247-52. doi: 10.1016/0002-9378(89)90676-5. Am J Obstet Gynecol. 1989. PMID: 2480065

9

Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.

Berchuck A, Soisson AP, Clarke-Pearson DL, Soper JT, Boyer CM, Kinney RB, McCarty KS Jr, Bast RC Jr. Berchuck A, et al. Among authors: soper jt. Cancer Res. 1989 Apr 15;49(8):2091-5. Cancer Res. 1989. PMID: 2702650

10

Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.

Berchuck A, Kohler MF, Hopkins MP, Humphrey PA, Robboy SJ, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC. Berchuck A, et al. Among authors: soper jt. Gynecol Oncol. 1994 Feb;52(2):232-6. doi: 10.1006/gyno.1994.1037. Gynecol Oncol. 1994. PMID: 7508877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters